4D Molecular Therapeutics

4D Molecular Therapeutics is a clinical-stage biotherapeutics company pioneering the development of targeted genetic medicines. We leverage our proprietary Therapeutic Vector Evolution (TVE) platform, combining directed evolution with a vast library of AAV capsid sequences, to create highly effective and targeted gene therapy products for a wide range of significant diseases. Unlike many gene therapy companies focused on rare diseases, 4DMT is tackling large market opportunities, offering significant potential for impact. Our fully integrated approach extends from research and development to in-house GMP manufacturing, allowing us to move rapidly from concept to clinical trials. We currently have five product candidates in clinical trials and two pre-clinical programs underway, showcasing our ability to innovate and execute. Our tech stack supports our agile and collaborative engineering culture, and includes technologies such as Google Tag Manager, Google Analytics, and various security protocols (SPF, SSL, DNSSEC, HSTS). We're committed to pushing boundaries in gene therapy, and our initial clinical data validates the power of our platform. 4DMT offers a dynamic and rewarding work environment. We're a growing company (101-250 employees) with a robust intellectual property portfolio and a strong financial foundation, evidenced by our significant funding rounds. We offer remote work opportunities for many roles, providing flexibility and access to talent across the United States and beyond. Our culture values collaboration, innovation, and a commitment to advancing gene therapy to improve patient lives. We are actively expanding our pipeline and exploring additional indications and modalities within genetic medicine, offering exciting opportunities for growth and advancement within the company. Our continued success in attracting top talent and securing substantial funding reinforces our position as a leader in the gene therapy field.